Additionally, specific small antibody fragments targeting the extracellular pore domain of Kv10.1 were exploited to selectively guide the Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) to tumor cells. This evidence concerns the gene KCNH1 and neoplasm.